This early research looked at a new COVID-19 DNA vaccine given to healthy adults. The goal was to see if the vaccine caused local reactions, such as pain at the injection site, or systemic reactions like fever. Participants also received a saline placebo for comparison. The team followed these 42 eligible subjects for up to six months to track their health.
The main results showed that no serious adverse events occurred from vaccination to six months. There were no discontinuations because of side effects, and specific safety data were not reported in detail. The study also measured immune responses, including antibodies and cellular activity, at the time of vaccination and again 30 days later.
Readers should understand that this is a Phase 1 study with a very small group of people. Because the sample size is so limited, these findings do not mean the vaccine is proven safe or effective for everyone. More large-scale studies are needed before this vaccine could be recommended for widespread use.